Aegera

Aegera Therapeutics was a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs in oncology and neuropathic pain. Aegera was acquired by PharmaScience in 2011.

Location

Verdun, Canada

History

Acquired by Pharmascience in 2011

Related companies

Rosetta Capital
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.